356 related articles for article (PubMed ID: 15023707)
1. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.
Wertheim HF; Vos MC; Ott A; Voss A; Kluytmans JA; Vandenbroucke-Grauls CM; Meester MH; van Keulen PH; Verbrugh HA
Ann Intern Med; 2004 Mar; 140(6):419-25. PubMed ID: 15023707
[TBL] [Abstract][Full Text] [Related]
2. Summaries for patients. Effects of antibiotic nose ointment for hospitalized patients with Staphylococcus aureus.
Ann Intern Med; 2004 Mar; 140(6):I36. PubMed ID: 15023733
[No Abstract] [Full Text] [Related]
3. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.
Perl TM; Cullen JJ; Wenzel RP; Zimmerman MB; Pfaller MA; Sheppard D; Twombley J; French PP; Herwaldt LA;
N Engl J Med; 2002 Jun; 346(24):1871-7. PubMed ID: 12063371
[TBL] [Abstract][Full Text] [Related]
4. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers.
van Rijen M; Bonten M; Wenzel R; Kluytmans J
Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD006216. PubMed ID: 18843708
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis.
Perl TM
Surgery; 2003 Nov; 134(5 Suppl):S10-7. PubMed ID: 14647028
[TBL] [Abstract][Full Text] [Related]
6. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
7. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
[TBL] [Abstract][Full Text] [Related]
8. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery.
Konvalinka A; Errett L; Fong IW
J Hosp Infect; 2006 Oct; 64(2):162-8. PubMed ID: 16930768
[TBL] [Abstract][Full Text] [Related]
9. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment.
Reagan DR; Doebbeling BN; Pfaller MA; Sheetz CT; Houston AK; Hollis RJ; Wenzel RP
Ann Intern Med; 1991 Jan; 114(2):101-6. PubMed ID: 1898585
[TBL] [Abstract][Full Text] [Related]
10. Preventing postoperative Staphylococcus infections: an update.
Grady M; Cullen JJ
Surg Technol Int; 2003; 11():57-60. PubMed ID: 12931284
[TBL] [Abstract][Full Text] [Related]
11. [Mupirocin: prophylaxis of hospital-acquired infections due to Staphylococcus aureus and sanitation of hospital environment].
Mitrokhin SD
Antibiot Khimioter; 2003; 48(9):13-9. PubMed ID: 15002175
[TBL] [Abstract][Full Text] [Related]
12. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
[TBL] [Abstract][Full Text] [Related]
13. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study.
Kalmeijer MD; Coertjens H; van Nieuwland-Bollen PM; Bogaers-Hofman D; de Baere GA; Stuurman A; van Belkum A; Kluytmans JA
Clin Infect Dis; 2002 Aug; 35(4):353-8. PubMed ID: 12145715
[TBL] [Abstract][Full Text] [Related]
14. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients.
Boelaert JR; De Smedt RA; De Baere YA; Godard CA; Matthys EG; Schurgers ML; Daneels RF; Gordts BZ; Van Landuyt HW
Nephrol Dial Transplant; 1989; 4(4):278-81. PubMed ID: 2502734
[TBL] [Abstract][Full Text] [Related]
15. Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents.
Watanakunakorn C; Axelson C; Bota B; Stahl C
Am J Infect Control; 1995 Oct; 23(5):306-9. PubMed ID: 8585642
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
18. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group.
J Am Soc Nephrol; 1996 Nov; 7(11):2403-8. PubMed ID: 8959632
[TBL] [Abstract][Full Text] [Related]
19. Mupirocin prophylaxis misses by a nose.
Chambers HF; Winston LG
Ann Intern Med; 2004 Mar; 140(6):484-5. PubMed ID: 15023716
[No Abstract] [Full Text] [Related]
20. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis.
Bloom BS; Fendrick AM; Chernew ME; Patel P
Am J Kidney Dis; 1996 May; 27(5):687-94. PubMed ID: 8629629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
